Immunic is trading 5% down at $14.33 today, July 16, 2026, driven by broader biotech sector weakness and a shift toward risk-off sentiment in growth stocks.
- The decline appears to be macro-driven, as there are no fresh company-specific headlines or filings to account for the move.
- The stock's performance aligns with a 2% drop in the biotech ETF (XBI) and general weakness across the Nasdaq.